incidence of urethane induced lung tumours bears a relationship to the incidence of spontaneous lung tumours in various inbred lines of mice. In this event, pentose nucleotides would be expected to have an inhibitory action on the formation of spontaneous lung tumours.
THE idea of somatic mutation as an explanation for the origin of cancer has had a long and interesting history. Its original use as an interpretation of cancer is usually associated with the names of Murray and of Boveri. These men arrived at the somatic mutation conclusion from different fields, Murray from experimental cancer research, and Boveri from his classical observations in experimental embryology. A -good description of the origin of cancer was formulated by Murray (1908) . At that time he stated: "The existence of such tumours, the biological characters of which are retained through long periods of propagation, shows that the cellular transformation which initiates carcinomatous growth may take place in varying degrees. The impress which the cells receive, at this time, while permitting of great histological variations in their descendants, q7 colours permanently their whole biological behaviour. This biological alteration is of such a kind that the cells are able to take up nourishment, increase in size and multiply indefinitely. They acquire an individuality and powers of resistance to injurious agencies superior to those of normal tissue elements."
Boveri's idea on the nature of the origin of cancer stemmed from his observations on atypical mitoses. He had suggested the possibility that by this means an unequal distribution of the chromosomes would ensue and thus lead to uncontrolled growth. He was loath to expand upon this concept until Aichel (1911) , using Boveri's own observations on the development of the sea urchin egg, arrived at the conclusion that a malignant tumour was caused by a fusion of a tissue cell with a leucocyte. Boveri's concept has not received wide recognition. The essential feature of the idea is expressed in his own words (Boveri, 1929) : "The essence of my theory is not abnormal mitosis, but in general, a definite abnormal chromosome-complex. However this may arise, the result would always be a definite tumour. Beside the multipolar mitoses, which might depend either on a simultaneous multidivision of the centrosome or on distorting the parallelism between the division of the centrosome and the cell-division, asymmetrical mitosis should be chiefly considered for the origin of tumours. Indeed, according to analogy with certain occurrences in sea urchins, these would depend on a lack in certain chromosomes of the power to divide; this would result far more surely in tumour than would multipolar mitoses, which depend on chance for the distribution of their chromatin. Agencies which would act most directly would be those that have the power of destroying definite chromosomes.of a cell, while leaving the others uninjured." Boveri, therefore, saw quite distinctly that irrespective of the mechanism of origin, the disturbed chromatin content is the essential feature in cellular physiology, including the abnormal condition of a tumorous growth. The Tyzzer (1916) expressed the opinion that a somatic mutation may be involved in the origin of cancer.
Tyzzer stated, "There are marked differences in the behaviour of various tumours on transplantation in given classes of mice. Even tumours arising in homogeneous races show such differences, and this may be attributed to the acquisition of new characteristics by the soma which are manifested in the development of the tumour. The tumour, since it breeds true with respect to these characteristics in the course of artificial propagation, may be regarded as a modification of the somatic tissue which may be termed somatic mutation."
At the present time it may be well to indicate two aspects of the genetic problem in relation to the origin of cancer. These are (1) susceptibility and resistance to the spontaneous, the transplanted and the induced tumour-an inherited constitutional state or states in which the germ plasm is definitely involved, and (2) the origin of the neoplastic lesion by a conversion, somehow or other, from a pre-existing normal somatic tissue-a somatic mutation. This actual process of somatic mutation may either be conditioned or under the control of an inherited or germinal influence, or entirely independent of such intrinsic determination. This distinction between the intrinsically determined susceptibility and resistance to cancer and the somatic origin by mutation is not always kept clearly in mind. As a matter of fact some investigators express the opinion that tb.e two genetic phenomena are entirely antagonistic to each other. For example, a very recent article by Bauer (1948) of Heidelberg discusses at length that susceptibility to cancer in the human population is not inherited, and at the same time elaborates on the development of the concept that cancer arises as a somatic mutation. Bauer states, "The decisive importance of inherited characteristics which give rise to cancer is entirely disproved by the experiment of nature with the hereditarily identical and the hereditarily different fraternal twins." Bauer has been interested in the somatic mutation hypothesis for many years, having published his first article in 1928 (Bauer, 1928) . Bauer (1948) concludes, "Thus the mutation theory of tumour development is an interpretation of all cancer phenomena adequate for the clinical, morphological, biochemical, and in particular genetical facts." A similarly expressed conflict between the germ plasm and the somatic mutation idea is expressed by Dunning, Curtis and Bullock, in which they arrive at the opposite conclusion in their extensive studies of induced sarcomas in the livers of rats, in that they conclude that susceptibility to the sarcoma condition is inherited, but that an ill-defined somatic mutation may also be involved in the origin of the lesion. This antagonism is, however, not as sharp as would be indicated by the title of their paper, "The Respective Roles of Heredity and Somatic Mutation in the Etiology of Tumors Induced by Parasites and Chemical Irritants' (Dunning, Curtis and Bullock, 1937) . In 1933 these investigators had concluded: "Possibly when more is known about the etiology of other tumours for which there appears to be an inherited susceptibility and when the expression of genetic factors in the cells and tissues is better understood, it will be found that in the case of all neoplasms in all species the initial cell change occurs by a process analogous to somatic mutation, and that heredity factors determine this change only in so far as they influence longevity and the susceptibility of an individual to some specific irritant or condition which is favourable to mutation" (Curtis, Dunning and Bullock, 1933, 1934) .
Their idea of the nature of this somatic mutation process in the origin of cancer is similar to the one expressed originally by Strong in 1926, who concluded: "This mutational process may be either a change or shifting of a complete chromosome or chromosomes, or a change or changes within a chromosome or chromosomes (genic), or it may be even cytoplasmic in nature. By mutation I merely mean to use the term in its broadest sense, that is, a change or shift within the genetic or internal constitution that results in definitely clear-cut or discernible differences in behaviour or structure that are perpetuated by the process of heredity (in this case, cell division)." (Strong, 1926a, b) . That a tendency to undergo somatic mutation may have a definite genetic basis in normal tissues has been discussed by East (1917) . This phenomenon has been encountered especially in plants, but also has been reported in the higher animals.
An early example of a genetic influence on somatic mutations is discussed by Whitman (1919 (1926) , Wilson (1924) and others in drosophila, by Federly (1936) in lepidopterous larvae, and by many other investigators. Most of these tumours are inherited by a multiple factor complex and, in the opinion of T. H. Morgan, expressed to the author many years ago, at least one of the drosophila tumours arose as a mutation.
Time alone prevents the further discussion of this interesting genetic material and its bearing on the somatic mutation hypothesis.
The next advance in the somatic mutation idea in relation to neoplastic lesions was undertaken by the present author, in 1918. From that time onward until 1930, a considerable amount of evidence was accumulated from the study of the transplantation of adenocarcinomata of the mammary gland in mice that eventually provided the first experimental evdence that a somatic mutation may be involved in the origin of cancer (Strong, 1926a, b (Strong, 1926a, b (Strong, 1926a (Strong, , 1926b . Another point that should also be emphasized is the fact that when the derived mutant transplantable tumour would grow in all F2 mice derived from a cross between the dilute brown and the A stocks, then, and not till then, would it grow in all mice irrespective of genetic relationship. In other words, it had lost all characteristics of tissue specificity.
The transplanted tumour would grow invasively at a tremendous rate and would metastasize extensively. Thus evidence was obtained that a highly specific, relatively benign, slow-growing transplantable tumour had progressively and suddenly acquired periodically new biological characteristics until finally it had been converted over into a carcinoma. The early sudden changes in the transplantability of the tumour were not accompanied by any changes in histological appearance. Toward the end of the series, however, especially at the terminal non-specific state, the tumour had become more cellular and had lost most of its original adenocarcinomatous arrangement.
Another series of investigations was performed on the transplantation of the 13 spontaneous tumours that mouse F1 79 gave rise to. This mouse was not only the common ancestor of the well known C, C3H, CBA, C121 and CHI strains of inbred mice, but also gave rise to a wealth of neoplastic tissue as follows: All 13 of her spontaneous tumours of mammary origin were tested out by trans-plantation in a series of suitable related mice. The data obtained from the study of two of these tumours, FjDa and F1Dg alone, have been published (Strong, 1929) . Thus, in a series of mice that had been injected with both tumours, one in the left axilla, the other in the right axilla, the data were obtained as shown in Table I . Thus it is evident the two transplantable tumours were giving a different reaction when transplanted into the same series of mice. There were similarities of reaction, however, as well as differences. Some mice would grow both tumours progressively, whereas other mice would refuse to grow either, and some showed temporary growth of both tumours. But in the same experiment it was found that a large series of 76 mice would show only a temporary growth of the G tumour but a progressive growth of the A tumour, and another group of 115 mice would refuse to grow the G tumour but would grow the A tumour. Further data obtained from the transplantation of these two tumours (FLDa and FjDg) are given in Table II . The study of these two tumours derived from the same mouse produced data that permitted the following conclusions. The two tumours, even in spite of the fact that they were derived from the same individual and were histologically indistinguishable, were indeed quite different. They were physiologically different, and presumably genetically different also. If one assumes, for the sake of argument, that one of these tumours possesses the same genetic constitution as the mouse tissue from which it arose, then the other tumour tissue cannot have it. This assumption is a valid one, since the recent interpretations of histogenesis would lead us to the conclusion that qualitative cell-divisions probably do not occur in animate forms. Every cell of the adult body is supposed to be endowed with the same genetic potentialities. Since, therefore, one of the tumours must have a different genetic constitution from the mouse tissues from which it has originated, it must have deviated, presumably by some such a process as somatic mutation, from the genetic constitution of the somatic tissue from which it arose. And if one tumour tissue has deviated from the genetic constitution of the somatic tissue from which it arose, then possibly all tumours undergo the same process in their origin.
The above phenomena especially of sudden changes taking place during the transplantability of spontaneous adenocarcinomas of the mammary gland in mice has been amply verified, not only by the investigation of the 11 other tumours derived from female F179 referred to previously, but also by many other tumours derived from other mice in my laboratory. All the phenomena of transplantation consistent with the genetic theory of transplantation were also verified by the independent work of Bittner (1931) and by Cloudman (1932a, b) . Eight years later Little (1934) wrote a review on the genetic work on the transplanted tumour in mice in which he included a discussion of the somatic mutation idea. In this paper Little points out that he had outlined the genetic basis for susceptibility and nonsusceptibility to transplanted tumours in 1914 (Little, 1914) . He states again in 1934 that "The bit of tumnour tissue to be transplanted has a genetic composition, which is determined by that of the animal in which it arises." If this idea was exclusively true, then it is obvious that a somatic mutation could not have been involved in its origin since any mutational process should alter or change the original genetic state. It is indeed true that in the early transfer generations, the transplanted tumour derived originally from a spontaneous source does retain the characteristic of tissue specificity determined by the genetic constitution of the mouse, in-that it will grow only in individuals which are genetically related to the mouse that gave rise to the tumour. But it has now been definitely proven that this phenomenon of tissue specificity is periodically and progressively lost by sudden changes resulting in simpler and simpler mendelian ratios, until eventually the tumour retains no or very little tissue specificity which it originally had. These sudden or mutational changes have always produced more and more malignancy, as determined by percentage of takes, growth rate and eventual invasive and metastatic characteristics. It has also been indicated that no two tumours, even though they be derived from the same mouse and present the same histological appearance, ever showed the same mendelian ratio when transplanted into a series of appropriate F2 individuals. When two transplantable tumours were derived from-the same mouse, some of the genetic complex involved in their successful transplantation is common to both tumours, whereas some are unique to either the one or the other tumour. Similarity of genetic transplantability complex indicates genetic relationship of origin for tumours. In this particular Little's concept of 1914 is therefore partially correct. It is also evident that the more recently chemicallyinduced tumours show, from their very origin, on an average, more malignancy, and thus less tissue specificity than do the spontaneous tumours that arise in the same series of inbred or hybrid mice. It is probably true, although at present impossible of proof, that there is some genetic mechanism within cells that determines to some extent normal cell relationship, but that under certain conditions this controlling genetic mechanism alters or changes, and by so doing permits an uncontrolled or cancerous-condition to arise somewhere in the biological system (the organism). This phenomenon of break of co-ordinating influence of a definitive part is, I believe, the essential feature in the origin of cancer. The fact that the tumour or cancer grows progressively is of secondary importance, following the experimental evidence reported by Strong (1926a, b) , and verified later by Bittner (1931) and by Cloudman (1932a, b) .
Little (1941) (Sturtevant, 1948) has now expressed the opinion that the indication of a gene can be determined by a method other than by the process of hybridization.
A different biological interpretation of the evidence bearing upon the origin of neoplastic growths has been expressed by Dahlberg (1940) . He states that "if tumours are regarded as descendants of a cell which has undergone mutation, it is understandable that tumour cells should show features differing from what is normal. Possibly we may also understand the autonomous character of the tumour tissues. On the other hand, the somatic-mutation theory hardly explains the embryonic features of malignant tumours; and it does not explain why growths are more frequent in older than in younger individuals, because it has not been observed that mutations in cells of the gonads are more frequent in older than in younger persons. Nor does it help us to understand why external stimulation should give rise to tumours, though it is possible to suggest more or less plausible analogies. Thus X-ray treatment may give rise to formations of tumours in the cells of the body and to mutations in the germ cells. A detail of particular interest is the occurrence of abnormalities among the chromosomes both in cells which have undergone mutation and in tumorous cells. The It is also a very significant fact that the mouse is the only animate form in which the characteristics of mutagenesis and carcinogenesis can be compared in the same species. Briefly stated, therefore, the problem of comparing the properties of mutagenesis and carcinogenesis for any given group of physical and chemical agents is comparing and contrasting two extremely variable characteristics which differ between different species and even between different individuals of the same species. The problem is even more complex than this, as will be indicated in the following discussion.
Not all of the biological variants obtained in mice with methylcholanthrene are genetic. The present author has tested many of these effects obtained in the descendants of mice receiving methylcholanthrene, and is forced to the conclusion that many results are non-genetic. These variants are not considered to be non-genetic until they fail to reappear in the double backcross generation to the variant condition following an outcross to a totally unrelated strain. Another class of frequent occurrence is the somatic mosaic. These individuals are somatic composites of two genotypes for which no evidence of inheritance can be obtained.
Another class of variants, such as the absence of one ovary alone or together with the congenital absence of one horn of the uterus is not genetic, and possibly may be explained in terms of specific inhibitions at particular or critical times of embryonic morphogenesis. It is a known fact that the carcinogens inhibit normal growth processes when injected into experimental animals, and there is no reason why this process of inhibition may not apply to the development of the embryo at critical periods of differentiation. The somatic mosaic may be due to a chromosomal aberration rather than a point mutation in somatic differentiation, although the actual mechanism involved in their origin cannot be determined.
We have obtained, therefore, a multiplicity of biological effects when methylcholanthrene has been injected into a series of mice over many generations.
Whether all these phenomena are due to the original methylcholanthrene or to one or many of the derived metabolites is still not known. Some of these effects are definite point mutations, some are non-genetic, some are non-genetic produced possibly by inhibitions of embryonic morphogenesis at critical periods, and other biological effects may have other mechanisms in their origin, such as abnormal distribution of chromosomes during morphogenesis.
But these mice whose ancestry has been injected with methylcholanthrene for many generations are not only giving rise to a wealth of biological effects, but also to a great variety of cancers. At least two genetic effects have been obtained in relation to induced tumours. The first genetic result was the production of germinal mutations which changed the rate at which fibrosarcomas appeared at the site of injection of methylcholanthrene (a decreased latent period). The second genetic effect was the production of spontaneous lesions involving the mucus-secreting cells of the gastric mucosa following the induction of this same gastric lesion from the subcutaneous injection of methylcholanthrene. The appearance of this specific type of pathological lesion was brought about by a mutation on the "brown tagged" chromosome. Several new sudden changes have appeared in the gastric lesion subline changing the latent period for the appearance of the lesion-a phenomenon that was obtained in the transplantation of adenocarcinomata of the mammary gland in mice and discussed in this same paper. Whether these new sudden changes are due to specific mutations may eventually be indicated.
The work on chemical carcinogenesis has provided much data of genetic interest. It appears now that the investigators of cancer can repay their debt to the investigators of general biology by reversing the process of borrowing observations in that field and to contribute information bearing on that science.
SUMMARY.
1. Sudden changes occur periodically in the transplantation of cancers in mice, which result in more malignant conditions by biological or genetic changes giving simpler and simpler mendelian ratios.
2. No two transplantable tumours ever have given the same mendelian ratio in the same series of F2 individuals, even though the tumours were derived from the same mouse and were histologically indistinguishable.
3. A multiplicity of biological effects have been induced in mice by methylcholanthrene for which different biological mechanisms must be responsible.
4. As a general rule all mutagens are carcinogens and all carcinogens are mutagens, but exceptions to the rule must be kept in mind.
5. The mouse is the only animal where carcinogenesis and mutagenesis can be compared in the same species.
6. By accepting the concept that cancer arises from a process of somatic mutation, a pessimistic attitude for its eventual control is not indicated.
